help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mercado, M.
Right arrow Articles by Baumann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mercado, M.
Right arrow Articles by Baumann, G.

Journal of Clinical Endocrinology & Metabolism, Vol 78, 731-735, Copyright © 1994 by Endocrine Society


ARTICLES

Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues

M Mercado, N DaVila, JF McLeod and G Baumann
Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611.

The extent of expression of the GH receptor (GHR) in human tissues is largely unknown. In some cell lines and placenta, the GHR gene generates two different mRNAs by alternative splicing of exon 3, one coding for a full-length receptor (GHR + 3) and the other for a receptor isoform that lacks exon 3 (GHR-3), with deletion of amino acid residues 7-28. To determine the distribution of the GHR and the relative abundance of its two isoforms in man, we studied a variety of tissues obtained at autopsy by reverse transcription and polymerase chain reaction (PCR) amplification, using isoform-specific primers. The nature of the PCR products was verified by restriction analysis and DNA sequencing. The relative proportions of the two GHR isoforms were determined by competitive PCR using a 32P-labeled anti-sense primer and a mixture of both isoform-specific sense primers in equimolar amounts. Electrophoretic bands corresponding to the amplification products were excised and counted, or quantitated by laser densitometry. Restriction analysis and sequencing of the amplified products were consistent with their predicted sequence. Both GHR transcripts were found in all 19 tissues tested, but their relative proportions varied depending on the tissue and, to a lesser extent, between subjects. They ranged from a preponderance of GHR-3 (kidney, bladder, adrenal, and brain stem) to a predominance of GHR + 3 (skeletal muscle and liver). We conclude that the GHR gene is widely expressed in human tissues. Both GHR + 3 and GHR- 3 transcripts are present, but their relative proportions depend on the tissue and, possibly, the metabolic status. The physiological significance of the existence of two human GHR forms remains to be elucidated.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. Pantel, J. Grulich-Henn, M. Bettendorf, C. J. Strasburger, U. Heinrich, and S. Amselem
Heterozygous Nonsense Mutation in Exon 3 of the Growth Hormone Receptor (GHR) in Severe GH Insensitivity (Laron Syndrome) and the Issue of the Origin and Function of the GHRd3 Isoform
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1705 - 1710.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Amit, M. B. H. Youdim, and Z.'e. Hochberg
Does Serum Growth Hormone (GH) Binding Protein Reflect Human GH Receptor Function?
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 927 - 932.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
A. Edens and F. Talamantes
Alternative Processing of Growth Hormone Receptor Transcripts
Endocr. Rev., October 1, 1998; 19(5): 559 - 582.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Zhou, B. C. Xu, H. G. Maheshwari, L. He, M. Reed, M. Lozykowski, S. Okada, L. Cataldo, K. Coschigamo, T. E. Wagner, et al.
A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)
PNAS, November 25, 1997; 94(24): 13215 - 13220.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. J. Lin, B. B. Mendonca, A. M. Lucon, I. C. de Mello Guazzelli, W. Nicolau, and S. M. F. Villares
Growth Hormone Receptor Messenger Ribonucleic Acid in Normal and Pathologic Human Adrenocortical Tissues--An Analysis by Quantitative Polymerase Chain Reaction Technique
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2671 - 2676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-F. Martini, A. Pezet, C. Y. Guezennec, M. Edery, M.-C. Postel-Vinay, and P. A. Kelly
Monkey Growth Hormone (GH) Receptor Gene Expression. EVIDENCE FOR TWO MECHANISMS FOR THE GENERATION OF THE GH BINDING PROTEIN
J. Biol. Chem., July 25, 1997; 272(30): 18951 - 18958.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. Clark
The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function
Endocr. Rev., April 1, 1997; 18(2): 157 - 179.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Pantel, K. Machinis, M.-L. Sobrier, P. Duquesnoy, M. Goossens, and S. Amselem
Species-specific Alternative Splice Mimicry at the Growth Hormone Receptor Locus Revealed by the Lineage of Retroelements during Primate Evolution. A NOVEL MECHANISM ACCOUNTING FOR PROTEIN DIVERSITY BETWEEN AND WITHIN SPECIES
J. Biol. Chem., June 16, 2000; 275(25): 18664 - 18669.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society